| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,064 |
11,963 |
$2.42M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,255 |
6,919 |
$1.09M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,522 |
6,034 |
$1.02M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
8,492 |
7,911 |
$695K |
| T1015 |
Clinic visit/encounter, all-inclusive |
7,899 |
3,677 |
$334K |
| G0378 |
Hospital observation service, per hour |
228 |
219 |
$217K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,846 |
1,789 |
$160K |
| 80053 |
Comprehensive metabolic panel |
16,296 |
15,002 |
$132K |
| 36415 |
Collection of venous blood by venipuncture |
22,016 |
19,255 |
$95K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
678 |
645 |
$93K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,844 |
4,413 |
$87K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,068 |
16,321 |
$79K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,283 |
1,163 |
$75K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
800 |
788 |
$71K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
600 |
563 |
$65K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,472 |
1,392 |
$61K |
| 80050 |
General health panel |
1,209 |
1,180 |
$56K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,240 |
3,860 |
$54K |
| 99215 |
Prolong outpt/office vis |
624 |
412 |
$51K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,737 |
3,308 |
$46K |
| 80061 |
Lipid panel |
3,082 |
3,006 |
$45K |
| 81513 |
|
407 |
397 |
$42K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,060 |
1,026 |
$42K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,716 |
1,660 |
$39K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,113 |
4,804 |
$36K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,465 |
3,132 |
$33K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
689 |
629 |
$29K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,591 |
2,408 |
$27K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
421 |
404 |
$25K |
| 76830 |
Ultrasound, transvaginal |
570 |
538 |
$24K |
| 84702 |
|
2,292 |
2,082 |
$23K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
617 |
582 |
$23K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
89 |
87 |
$21K |
| 59025 |
Fetal non-stress test |
97 |
71 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
1,469 |
1,418 |
$20K |
| 70450 |
Computed tomography, head or brain; without contrast material |
475 |
451 |
$20K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
153 |
144 |
$20K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
800 |
788 |
$19K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
256 |
253 |
$19K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
319 |
300 |
$17K |
| 96376 |
|
489 |
327 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,346 |
2,284 |
$17K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
351 |
335 |
$17K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
383 |
349 |
$17K |
| 84484 |
|
2,148 |
1,916 |
$15K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
571 |
434 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,313 |
2,110 |
$14K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
634 |
609 |
$14K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
233 |
229 |
$14K |
| 71250 |
|
168 |
166 |
$13K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
437 |
427 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
608 |
584 |
$12K |
| T1001 |
Nursing assessment / evaluation |
60 |
57 |
$12K |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
558 |
500 |
$12K |
| 81001 |
|
6,802 |
6,350 |
$12K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
56 |
54 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,436 |
1,198 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,717 |
1,519 |
$11K |
| 95886 |
|
237 |
230 |
$11K |
| 87481 |
|
172 |
158 |
$11K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
362 |
342 |
$10K |
| 93971 |
|
175 |
167 |
$10K |
| 83880 |
|
463 |
429 |
$10K |
| 84466 |
|
642 |
614 |
$10K |
| 83690 |
|
3,307 |
3,076 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
200 |
189 |
$9K |
| 76642 |
|
217 |
210 |
$9K |
| 86803 |
|
383 |
374 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
184 |
104 |
$8K |
| 85027 |
|
1,180 |
1,066 |
$8K |
| 72110 |
|
377 |
367 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,027 |
2,632 |
$7K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
146 |
117 |
$7K |
| 83735 |
|
1,542 |
1,332 |
$7K |
| 95800 |
|
85 |
82 |
$7K |
| 73564 |
|
377 |
325 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
1,476 |
1,402 |
$7K |
| 82607 |
|
616 |
589 |
$7K |
| 86618 |
|
262 |
253 |
$6K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
179 |
173 |
$6K |
| 82728 |
|
589 |
559 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
263 |
256 |
$6K |
| 84439 |
|
691 |
673 |
$6K |
| 87040 |
|
502 |
459 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
124 |
118 |
$6K |
| 76801 |
|
147 |
138 |
$5K |
| 83540 |
|
680 |
650 |
$5K |
| 76536 |
|
92 |
91 |
$5K |
| 85610 |
|
1,783 |
1,391 |
$5K |
| 84703 |
|
695 |
661 |
$5K |
| 82570 |
|
643 |
601 |
$5K |
| 76770 |
|
131 |
117 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
71 |
68 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
275 |
259 |
$4K |
| 87077 |
|
601 |
564 |
$4K |
| 72050 |
|
161 |
157 |
$4K |
| 86038 |
|
256 |
243 |
$4K |
| 83605 |
|
866 |
780 |
$4K |
| 83655 |
|
321 |
315 |
$4K |
| 73610 |
|
229 |
214 |
$4K |
| 82043 |
|
433 |
420 |
$4K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
15 |
15 |
$3K |
| 87186 |
|
456 |
435 |
$3K |
| 73030 |
|
240 |
212 |
$3K |
| 82784 |
|
133 |
129 |
$3K |
| 73630 |
|
286 |
265 |
$3K |
| 87653 |
|
70 |
69 |
$3K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
701 |
677 |
$3K |
| 82075 |
|
288 |
265 |
$3K |
| 85730 |
|
683 |
636 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
260 |
253 |
$3K |
| 83013 |
|
39 |
38 |
$3K |
| S9470 |
Nutritional counseling, dietitian visit |
154 |
150 |
$3K |
| 87340 |
|
178 |
174 |
$3K |
| 87799 |
|
31 |
31 |
$3K |
| 85379 |
|
390 |
373 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
59 |
58 |
$2K |
| J1756 |
Injection, iron sucrose, 1 mg |
304 |
145 |
$2K |
| 93970 |
|
27 |
26 |
$2K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
43 |
25 |
$2K |
| 84146 |
|
89 |
86 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
55 |
54 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$2K |
| 84403 |
|
72 |
69 |
$2K |
| 82565 |
|
571 |
528 |
$2K |
| 85652 |
|
678 |
610 |
$2K |
| 74022 |
|
107 |
105 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
45 |
44 |
$2K |
| 86592 |
|
413 |
401 |
$2K |
| 84100 |
|
322 |
267 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
31 |
27 |
$2K |
| 73130 |
|
179 |
150 |
$2K |
| 90715 |
|
92 |
81 |
$2K |
| 86140 |
|
603 |
547 |
$2K |
| 72070 |
|
89 |
88 |
$2K |
| 73110 |
|
136 |
120 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
25 |
25 |
$1K |
| 86850 |
|
218 |
203 |
$1K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
12 |
12 |
$1K |
| 86003 |
|
12 |
12 |
$1K |
| 80076 |
|
149 |
140 |
$1K |
| 84153 |
|
56 |
53 |
$1K |
| 77066 |
Tomosynthesis, mammo |
13 |
13 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,298 |
1,240 |
$1K |
| 86480 |
|
16 |
16 |
$1K |
| 94760 |
|
23 |
13 |
$1K |
| 93017 |
|
37 |
37 |
$1K |
| 83001 |
|
63 |
60 |
$1K |
| 82248 |
|
238 |
206 |
$1K |
| 84550 |
|
181 |
163 |
$1K |
| 73502 |
|
65 |
63 |
$1K |
| 82947 |
|
514 |
398 |
$1K |
| 83516 |
|
32 |
32 |
$963.10 |
| 82746 |
|
93 |
91 |
$934.72 |
| 87512 |
|
32 |
32 |
$904.04 |
| 86900 |
|
280 |
259 |
$845.36 |
| 86901 |
|
280 |
259 |
$845.27 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
38 |
38 |
$805.60 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,365 |
1,190 |
$770.51 |
| 84156 |
|
180 |
150 |
$733.29 |
| 86431 |
|
94 |
94 |
$709.74 |
| 86706 |
|
43 |
43 |
$603.12 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
781 |
607 |
$574.76 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,983 |
3,824 |
$549.80 |
| 97165 |
|
14 |
14 |
$540.12 |
| 80164 |
|
29 |
29 |
$539.98 |
| 83970 |
|
12 |
12 |
$531.28 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,322 |
3,623 |
$530.29 |
| 93296 |
|
41 |
41 |
$525.99 |
| 82950 |
|
70 |
69 |
$509.96 |
| 87493 |
|
13 |
13 |
$495.95 |
| 82550 |
|
88 |
82 |
$478.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,733 |
1,422 |
$428.53 |
| 84402 |
|
13 |
13 |
$403.65 |
| 94729 |
|
12 |
12 |
$365.98 |
| 81003 |
|
115 |
104 |
$361.51 |
| 83615 |
|
67 |
57 |
$355.00 |
| 87427 |
|
27 |
27 |
$333.56 |
| A9270 |
Non-covered item or service |
38 |
26 |
$323.75 |
| 87081 |
|
58 |
57 |
$319.02 |
| 77062 |
|
12 |
12 |
$302.55 |
| 87205 |
|
67 |
65 |
$300.13 |
| 84481 |
|
13 |
13 |
$296.12 |
| 87209 |
|
13 |
13 |
$261.15 |
| 94727 |
|
12 |
12 |
$242.45 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
335 |
306 |
$235.26 |
| 72040 |
|
12 |
12 |
$224.93 |
| 87070 |
|
39 |
38 |
$223.75 |
| 72100 |
|
12 |
12 |
$220.78 |
| 73140 |
|
24 |
24 |
$201.30 |
| 90686 |
|
13 |
13 |
$189.80 |
| 87045 |
|
27 |
27 |
$188.98 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,894 |
1,404 |
$185.81 |
| 74018 |
|
16 |
13 |
$180.47 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$175.32 |
| J2704 |
Injection, propofol, 10 mg |
390 |
365 |
$148.06 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$148.00 |
| J2060 |
Injection, lorazepam, 2 mg |
518 |
401 |
$146.14 |
| 82803 |
|
28 |
24 |
$141.96 |
| 80178 |
|
17 |
13 |
$128.00 |
| 94060 |
|
12 |
12 |
$125.97 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
230 |
164 |
$120.30 |
| 87046 |
|
27 |
27 |
$117.45 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
721 |
544 |
$113.16 |
| 84425 |
|
13 |
13 |
$106.75 |
| 87177 |
|
13 |
13 |
$97.54 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
118 |
96 |
$61.22 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
349 |
293 |
$31.73 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
25 |
13 |
$30.18 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
396 |
334 |
$25.75 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
53 |
30 |
$15.33 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
232 |
212 |
$3.96 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
105 |
90 |
$0.01 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
154 |
150 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
157 |
139 |
$0.00 |
| J3490 |
Unclassified drugs |
184 |
89 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
19 |
13 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
178 |
152 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
396 |
335 |
$0.00 |